The likelihood of help or harm, also known as the risk/benefit ratio, was found to be more favorable for lithium.
Your search for major depressive disorder returned 113 results
Active Filters
Click on a filter below to refine your search. Remove a filter to broaden your search.
This was a study protocol for a phase II pilot feasibility study that will assess the feasibility of ketamine for depression in patients with advanced life-limiting illnesses.
Ensemble is an AI-powered digital mental health coach app designed to address the symptoms of MDD or GAD.
Suicidal ideation, plan, and attempt in young U.S. adults increased from 2008-2009 to 2018-2019 after controlling for MDE, cannabis use, and CUD.
For TRMD, 25 percent nitrous oxide has comparable efficacy to 50 percent nitrous oxide, with a lower rate of adverse effects.
Major depressive episodes reduce visual contrast suppression among patients with depressive disorders, a study shows.
A team of researchers assessed a 60-year-old women diagnosed with painless legs and moving toes syndrome linked to multiple system atrophy and the efficacy of levodopa treatment.
For Chinese adults with normal kidney function, higher depressive symptoms are associated with an increased risk for rapid kidney function decline.
This genome-wide associated study expanded on the gene-environment correlation for childhood maltreatment and causal relationship between childhood maltreatment and health.
People with epilepsy are more likely to experience psychiatric comorbidities, which can have a highly negative effect on their condition, their mental state, and their overall quality of life. What are some of the effects stress and depression can have on a patient’s epilepsy?
In order to assess asymptomatic infections and immunologic responses to COVID-19, a team of researchers tested for SARS-CoV-2 antibodies in a multiple sclerosis cohort.
Psilocybin has been shown to have antidepressant properties. With direct comparisons between psilocybin and established treatments for depression lacking, the study researchers looked at psilocybin and escitalopram.
AXS-05 consists of dextromethorphan, an NMDA receptor antagonist, and bupropion, a norepinephrine and dopamine reuptake inhibitor.
Researchers compared how patients experiencing a major depressive episode and control participants perceived contrast patterns.
For patients with MDD, the change in scores for depression at six weeks does not differ significantly with psilocybin or psilocybin plus escitalopram.
To evaluate whether patients with isolated dystonia are at an increased risk for suicidal behavior, researchers administered an anonymous electronic survey.
The researchers sought to estimate the age-specific incidence and prevalence of dementia diagnoses among older adults with schizophrenia in the United States compared to those without serious mental illness.
The percentage of adults with mental health issues increased, as did the percentage reporting that they needed but did not receive help.
For people with dementia with symptoms of depression, without a MDD, nondrug interventions are more efficacious than drug interventions.
Solriamfetol, a dopamine-norepinephrine reuptake inhibitor, improves excessive daytime sleepiness in OSA regardless of primary OSA therapy adherence.
Globally, among health care workers, there has been a high prevalence of depression, anxiety, and PTSD during the COVID-19 pandemic.
A team of researchers sought to investigate the bidirectional relationship between multiple sclerosis and major depressive disorder with Mendelian randomization.
More than half of individuals with prior COVID-19 illness have met the criteria for symptoms of major depressive disorder.
-
Latest News Your top articles for Tuesday
For More Personalized News -
Haymarket Medical NetworkTop Picks
- Loading...
Continuing Medical Education (CME/CE) Courses